Likewise, a mutation in the KRAS proto-oncogene facilitates the second step in the carcinogenesis of 1 subtype of CRC.23 This alteration plays a pivotal role in some NCRCs' pathogenesis as well 24-26. The gene discussed is KRAS; the disease is colorectal carcinoma.